Search Results
Aug 14, 2026, 16:01 ET FiEE, Inc. Announces Second Quarter and First Half 2026 Unaudited Financial Results
future financial position and results of operations of the Company, (ii) our ability to successfully implement our strategic business transformation, (iii) our commitment to investing in R&D and our ability to execute on our AI music and home entertainment initiatives, including our expectations regarding
More news about: FiEE, Inc.
Aug 14, 2026, 12:22 ET Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II
the Federal Register to initiate the process of reclassifying cystoscopic systems intended as an aid for the detection of bladder cancer from Class III to Class II. Importantly, FDA is initiating the proposed reclassification on its own initiative following its review of available scientific,
More news about: Photocure
Aug 14, 2026, 12:18 ET Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II
the Federal Register to initiate the process of reclassifying cystoscopic systems intended as an aid for the detection of bladder cancer from Class III to Class II. Importantly, FDA is initiating the proposed reclassification on its own initiative following its review of available scientific,
More news about: Photocure
Aug 14, 2026, 08:03 ET Zoomcar Delivers Record Contribution Profit of $1.65 Million; Margin per Booking Rises to 70% or $18.75
Adjusted EBITDA is a non-GAAP financial measure that represents our net income or loss adjusted for (i) depreciation and amortization (ii) finance costs, (iii) Gain on troubled debt restructuring and (iv) Other income/Expense.Contribution Profit/(Loss)The following is the calculation of Contribution
More news about: Zoomcar
Aug 14, 2026, 08:00 ET Suncrete Announces Q2 2026 Earnings Results
continues to expand, providing additional opportunities to build scale in our existing markets and enter attractive new geographies."Ned N. Fleming, III, the Company's Executive Chairman, stated, "We are proud of our team's exceptional execution this quarter as we continue to advance Suncrete's long-term
More news about: Suncrete, Inc.
Aug 14, 2026, 06:34 ET ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial
diseases.Ziresovir Advances to Treat Severely Infected Infant PatientsZiresovir is the first direct RSV antiviral drug to successfully complete a phase III clinical trial with positive results. The clinical study in 1-24 months age patients conducted in China demonstrated that ziresovir can significantly
More news about: Shanghai Ark Biopharmaceutical Co., Ltd.
Aug 14, 2026, 06:08 ET ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial
diseases.Ziresovir Advances to Treat Severely Infected Infant PatientsZiresovir is the first direct RSV antiviral drug to successfully complete a phase III clinical trial with positive results. The clinical study in 1-24 months age patients conducted in China demonstrated that ziresovir can significantly
More news about: Shanghai Ark Biopharmaceutical Co., Ltd.
Aug 14, 2026, 06:05 ET 30 DAY INVESTOR NOTICE: GPGI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - GPGI
track to achieve the revenue and Adjusted EBITDA targets provided in the proxy statement and such targets lacked a reasonable basis in objective fact; (iii) a primary motivation of the Husky Acquisition was to generate millions of dollars in fees for Resolute Holdings and the individual defendants, rather
More news about: Robbins Geller Rudman & Dowd LLP
Aug 14, 2026, 05:45 ET Hyperscale Data Has Sold Approximately 685 Bitcoin for Approximately $43 Million, Reduces Debt by Approximately $30 Million and Strengthens Liquidity to Support Michigan Data Center Buildout
important part of Hyperscale Data's strategy and we expect it to remain an important part of our strategy going forward," stated Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "We intend to continue mining Bitcoin and, over time, expect to use mining production and available capital to
More news about: Hyperscale Data Inc.
Aug 14, 2026, 03:36 ET The First Year of World Models: When AI's Supply-Side Revolution Moves from Generation to Understanding the Physical World
fast reactions." The supply-side revolution has produced something qualitatively new: not a video generator, but an interactive, living world.III. Data as the Foundation: Letting AI "Understand" Rather Than Merely "See"Beneath the technical breakthroughs lies a more foundational insight.
More news about: Kunlun Tech
Aug 13, 2026, 22:44 ET INTU INVESTOR DEADLINE: Intuit Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 8, 2026 Deadline
tax-related business, particularly in its Turbo Tax business, as a result of, among other things, increasing competitive and pricing pressures; and (iii) accordingly, Intuit's previously issued 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic.On May 20, 2026, during pre-market
More news about: Robbins Geller Rudman & Dowd LLP
Aug 13, 2026, 16:51 ET Perimeter Schedules Second Quarter 2026 Financial Results Conference Call for August 20th
material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include,
More news about: Perimeter Medical Imaging AI Inc.
Aug 13, 2026, 16:50 ET Lument Finance Trust Reports Second Quarter 2026 Results and Announces Reverse Stock Split
realized losses not otherwise included in GAAP net income (loss) and excluding (i) non-cash equity compensation, (ii) depreciation and amortization, (iii) any unrealized gains or losses or other similar non-cash items that are included in net income for that applicable reporting period, regardless of whether
More news about: Lument Finance Trust, Inc.
Aug 13, 2026, 16:15 ET Nektar Therapeutics Announces Second Quarter 2026 Financial Results
including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are in various stages of preclinical and clinical development, the risk of failure is high and
More news about: Nektar Therapeutics
Aug 13, 2026, 16:10 ET cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
defines Adjusted EBITDA as GAAP loss from operations adjusted to (i) depreciation and amortization, (ii) stock-based compensation expense, (iii) inventory reserve, (iii) regulatory and legal matters, and (iv) mergers and acquisitions and financing transaction expenses for the periods presented. cbdMD, Inc.
More news about: cbdMD, Inc.
Aug 13, 2026, 16:05 ET DAWSON GEOPHYSICAL REPORTS SECOND QUARTER 2026 RESULTS
and Exchange Commission. The Company defines Adjusted EBITDA as our net income, before (i) interest expense, net, (ii) income tax expense or benefit, (iii) depreciation and amortization and (iv) non-recurring and other charges that we believe are not indicative of our core operating performance, such as
More news about: Dawson Geophysical Company
Aug 13, 2026, 16:01 ET Co-Diagnostics Reports Second Quarter 2026 Financial Results
commercialization of the Co-Dx PCR platform and related tests; (ii) anticipated timing and progress of clinical studies and regulatory submissions; (iii) the Company's ability to develop, scale, and commercialize its manufacturing capabilities, including through CoSara and CoMira and other third parties;
More news about: Co-Diagnostics
Aug 13, 2026, 16:01 ET AudioEye Reports Record Second Quarter 2026 Results
extinguishment of debt, and plus lost deposit on alternative financing; (ii) Adjusted EBITDA margin as Adjusted EBITDA as a percentage of GAAP revenue; and (iii) Adjusted earnings (loss) per diluted share (EPS) as net income (loss) per diluted common share, plus interest expense, plus depreciation and amortization
More news about: AudioEye, Inc.
Aug 13, 2026, 15:58 ET 46 Greenberg Traurig Lawyers Recognized on 2026 Lawdragon 500 Leading Real Estate Lawyers List
Sherman W. Smith, III: Philadelphia; Real Estate, Finance, Investment
More news about: Greenberg Traurig, LLP
Aug 13, 2026, 12:50 ET REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
concerning the Phase III Fianlimab-Libtayo Study.Q: What specific misstatements does the REGN lawsuit allege? A: The complaint alleges Regeneron made materially false or misleading statements regarding the risk of clinical failure in the Phase III Fianlimab-Libtayo
More news about: SueWallSt.com
Aug 13, 2026, 10:31 ET Bronchiectasis Market is Expected to Surge at a CAGR of 15% by 2036, Owing to the Launch of DPP1/CatC Inhibitors, Therapeutic Phage Cocktails, Nebulized Mucoactive Agents, and Other Novel Mechanisms | DelveInsight
Designation (BTD) and Fast Track Designation (FTD) from the US FDA, with BTD granted in 2024. In July 2025, Boehringer Ingelheim initiated a Phase III clinical trial to further assess the safety and efficacy of verducatib in patients with bronchiectasis.Armata Pharmaceuticals' AP-PA02 is
More news about: DelveInsight Business Research, LLP
Aug 13, 2026, 10:30 ET Disposable Medical Sensors Market worth $16.13 billion by 2031 - Exclusive Report by MarketsandMarkets™
Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Orthopedic, Dental), Class of Device (Class I, II, III), Service (Device Development & Manufacturing, Packaging & Assembly, Quality Management) - Global Forecast to 2030
More news about: MarketsandMarkets
Aug 13, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers - DVLT
for a $40,000 fine and a three-year ban from participating in a penny stock offering. Nor did the Company's announcement disclose that Edward Withrow III ("Withrow"), an individual listed as inventor alongside Defendant Bradley on multiple Data Vault Holdings patents, had a previous felony conviction for
More news about: Pomerantz LLP
Aug 13, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Intuit Inc. and Certain Officers - INTU
marketing products and services in the United States. The Company has four reportable business segments: (i) Global Business Solutions; (ii) Consumer; (iii) Credit Karma; and (iv) ProTax. Intuit's Consumer segment provides do-it-yourself ("DIY") and assisted income tax preparation products and services
More news about: Pomerantz LLP
Aug 13, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
joining the class action]On April 29, 2026, during during Regeneron's first quarter earnings call, the Company disclosed that the Phase III Fianlimab-Libtayo Study had been altered, expanding the number of patients in the study eligible for "analysis of progression-free survival." On
More news about: Pomerantz LLP